AI Platform for Structure-Guided Molecular Discovery
A secure, no-code platform for structure-guided discovery and AI-powered design of small molecules, peptides, nanobodies, antibodies and mini-binders.
A secure, no-code platform for structure-guided discovery and AI-powered design of small molecules, peptides, nanobodies, antibodies and mini-binders.
Go beyond structure prediction. Understand what a structure means for discovery.
CycloGen connects structural biology, AI and computational chemistry across the discovery workflow — from target and structure analysis to therapeutic design and candidate evaluation.
From protein structure to experimentally testable candidates — in one integrated no-code environment.
Integrated structural and molecular intelligence across early-stage therapeutic discovery.
Structure analysis, quality assessment, binding-site detection and molecular interaction intelligence.
Evaluate therapeutic targets, structural features, pockets and discovery opportunities.
Structure-guided ligand discovery, docking, screening and candidate evaluation.
AI-guided design workflows for nanobodies, antibodies, mini-binders and peptides.
Structural, interaction, mutation and developability analysis for candidate prioritization.
Secure deployment designed for proprietary biotech and pharmaceutical R&D.
Scientific tools for structure-guided therapeutic discovery
Engineer compact single-domain antibodies with enhanced stability and unique binding capabilities.
Engineer compact, high-affinity binders for diagnostic and therapeutic applications.
Predict protein structures with state-of-the-art deep learning models.
Identify and validate novel therapeutic targets through computational analysis.
Analyze mutation impact on protein function, stability and drug resistance.
Discover and optimize small molecule ligands using structure-guided docking and scoring.
Built for Proprietary Drug Discovery
Deploy CycloGen within your own infrastructure and run integrated drug discovery workflows while keeping proprietary sequences, structures and molecular data inside your environment.
On-Premises
Deploy within enterprise-controlled infrastructure.
No-Code
Integrated computational discovery workflows through a visual interface.
Private R&D
Keep proprietary discovery data within your controlled environment.
The platform combines structural biology, computational chemistry and AI to support evidence-driven candidate prioritization across early-stage therapeutic discovery.
See how CycloGen can support your early-stage drug discovery workflows.
Or contact us directly at sales@cyclogen.ai